Bank of New York Mellon
SPRB

Bank of New York Mellon’s Spruce Biosciences SPRB Stock Holding History

Bank of New York Mellon’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+6,779
New +$379K ﹤0.01% 3896
2023
Q4 		– Sell
-1,188
Closed -$201K – 4399
2023
Q3 		$201K Sell
1,188
-31
-3% -$5.22K ﹤0.01% 3957
2023
Q2 		$197K Sell
1,219
-9
-0.7% -$1.5K ﹤0.01% 3977
2023
Q1 		$203K Hold
1,228
– – ﹤0.01% 3914
2022
Q4 		$101K Sell
1,228
-9
-0.7% -$753 ﹤0.01% 4113
2022
Q3 		$127K Hold
1,237
– – ﹤0.01% 4154
2022
Q2 		$161K Sell
1,237
-316
-20% -$40.5K ﹤0.01% 4132
2022
Q1 		$234K Buy
1,553
+1,181
+317% +$220K ﹤0.01% 4161
2021
Q4 		$124K Buy
372
+6
+2% +$1.79K ﹤0.01% 4374
2021
Q3 		$165K Buy
366
+25
+7% +$15.7K ﹤0.01% 4250
2021
Q2 		$286K Buy
341
+85
+33% +$90.7K ﹤0.01% 3984
2021
Q1 		$318K Buy
256
+76
+42% +$117K ﹤0.01% 3885
2020
Q4 		$328K Buy
+180
New +$298K ﹤0.01% 3793

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Bank of New York Mellon's SPRB Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 6,779 shares worth $366K. The stake represents ﹤0.01% of the portfolio and ranks #3896 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in SPRB as recently as Q3 2023.

Bank of New York Mellon first reported a position in SPRB in Q4 2020 and has held it in 13 quarters since. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Bank of New York Mellon held 6,779 shares of Spruce Biosciences worth $366K as of Q2 2026.
  • Spruce Biosciences was a new Bank of New York Mellon position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3896 holding.
  • Bank of New York Mellon first reported a position in Spruce Biosciences in Q4 2020 and has held it in 13 quarters since.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.